bucladesine has been researched along with euxanthone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, DK; DiMattia, GE; Mak, NK; Wagner, GF; Wong, CK; Yeung, HY | 1 |
| Chan, DK; Mak, NK; Wagner, GF; Wong, CK; Yeung, HY | 1 |
2 other study(ies) available for bucladesine and euxanthone
| Article | Year |
|---|---|
Effects of dibutyryl cAMP on stanniocalcin and stanniocalcin-related protein mRNA expression in neuroblastoma cells.
Topics: Animals; Bucladesine; Cell Differentiation; Dose-Response Relationship, Drug; Gene Expression Regulation; Glycoproteins; Hormones; Ionomycin; Ionophores; Mice; Neurites; Neuroblastoma; Neurons; Oligonucleotides, Antisense; RNA, Messenger; Stimulation, Chemical; Time Factors; Tumor Cells, Cultured; Xanthenes; Xanthones | 2002 |
Identification of signal transduction pathways that modulate dibutyryl cyclic adenosine monophosphate activation of stanniocalcin gene expression in neuroblastoma cells.
Topics: Animals; Antineoplastic Agents; Bucladesine; Calcium; Cell Differentiation; Drug Interactions; Gene Expression Regulation; Glycoproteins; Hormones; Mice; Neuroblastoma; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured; Xanthenes; Xanthones | 2003 |